China speeds up drug development during “135”

According to a director of the National Health and Family Planning Commission, 95 % of patented drugs and 95 % of major medical equipment in China are still under patent protection from foreign companies. During the present 5 years plan (“135”), the government has...

Bayer China to support 4 Chinese healthcare startups

Within its grants4apps program, https://www.grants4apps.com/shanghai/index_en.html, the company has selected 4 out of 130 start-up candidates for training and support. The startups are a) Tuo Xiao Intelligent, committed to the development of a home stethoscope and...

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny